224 related articles for article (PubMed ID: 20689826)
1. Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Siu KW
PLoS One; 2010 Aug; 5(8):e11939. PubMed ID: 20689826
[TBL] [Abstract][Full Text] [Related]
2. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of prothymosin alpha predicts poor disease outcome in head and neck cancer.
Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; Dattagupta S; Sharma MC; Ralhan R; Siu KW
PLoS One; 2011 May; 6(5):e19213. PubMed ID: 21573209
[TBL] [Abstract][Full Text] [Related]
4. Epidermal differentiation complex (locus 1q21) gene expression in head and neck cancer and normal mucosa.
Tyszkiewicz T; Jarzab M; Szymczyk C; Kowal M; Krajewska J; Jaworska M; Fraczek M; Krajewska A; Hadas E; Swierniak M; Markowski J; Lange D; Poltorak S; Wiench M; Krecicki T; Jarzab J; Maciejewski A
Folia Histochem Cytobiol; 2014; 52(2):79-89. PubMed ID: 25007175
[TBL] [Abstract][Full Text] [Related]
5. DNA Methylome Distinguishes Head and Neck Cancer from Potentially Malignant Oral Lesions and Healthy Oral Mucosa.
Milutin Gašperov N; Sabol I; Božinović K; Dediol E; Mravak-Stipetić M; Licastro D; Dal Monego S; Grce M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961999
[TBL] [Abstract][Full Text] [Related]
6. Discovery and verification of head-and-neck cancer biomarkers by differential protein expression analysis using iTRAQ labeling, multidimensional liquid chromatography, and tandem mass spectrometry.
Ralhan R; Desouza LV; Matta A; Tripathi SC; Ghanny S; Datta Gupta S; Bahadur S; Siu KW
Mol Cell Proteomics; 2008 Jun; 7(6):1162-73. PubMed ID: 18339795
[TBL] [Abstract][Full Text] [Related]
7. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
8. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous ribonucleoprotein K is a marker of oral leukoplakia and correlates with poor prognosis of squamous cell carcinoma.
Matta A; Tripathi SC; DeSouza LV; Grigull J; Kaur J; Chauhan SS; Srivastava A; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Michael Siu KW
Int J Cancer; 2009 Sep; 125(6):1398-406. PubMed ID: 19548310
[TBL] [Abstract][Full Text] [Related]
10. Risk estimation for a malignant transformation of oral lesions by S100A7 and Doc-1 gene expression.
Winter J; Pantelis A; Reich R; Jepsen S; Allam JP; Novak N; Wenghoefer M
Cancer Invest; 2011 Aug; 29(7):478-84. PubMed ID: 21740085
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
12. Elevated gastrin-releasing peptide receptor mRNA expression in buccal mucosa: association with head and neck squamous cell carcinoma.
Egloff AM; Liu X; Davis AL; Trevelline BK; Vuga M; Siegfried JM; Grandis JR
Head Neck; 2013 Feb; 35(2):270-9. PubMed ID: 22431275
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of head-and-neck cancer biomarkers previously discovered and identified using iTRAQ-labeling and multidimensional liquid chromatography-tandem mass spectrometry.
Matta A; DeSouza LV; Shukla NK; Gupta SD; Ralhan R; Siu KW
J Proteome Res; 2008 May; 7(5):2078-87. PubMed ID: 18407684
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
16. Identification of head and neck squamous cell carcinoma biomarker candidates through proteomic analysis of cancer cell secretome.
Marimuthu A; Chavan S; Sathe G; Sahasrabuddhe NA; Srikanth SM; Renuse S; Ahmad S; Radhakrishnan A; Barbhuiya MA; Kumar RV; Harsha HC; Sidransky D; Califano J; Pandey A; Chatterjee A
Biochim Biophys Acta; 2013 Nov; 1834(11):2308-16. PubMed ID: 23665456
[TBL] [Abstract][Full Text] [Related]
17. Assessing Oral Epithelial Dysplasia Risk for Transformation to Cancer: Comparison Between Histologic Grading Systems Versus S100A7 Immunohistochemical Signature-based Grading.
Darling MR; Hwang JTK; Dickson BJ; Cutz JC; Salama S; McCord C; Pritzker KPH; Mock D; Thompson LDR
Appl Immunohistochem Mol Morphol; 2023 Jul; 31(6):399-405. PubMed ID: 37249075
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of nuclear ING3 expression and translocalization to cytoplasm promotes tumorigenesis and progression in head and neck squamous cell carcinoma (HNSCC).
Li X; Zhang Q; Zhang M; Luo Y; Fu Y
Histol Histopathol; 2020 Jul; 35(7):681-690. PubMed ID: 31886514
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
[TBL] [Abstract][Full Text] [Related]
20. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
Waseem A; Ali M; Odell EW; Fortune F; Teh MT
Oral Oncol; 2010 Jul; 46(7):536-42. PubMed ID: 20400365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]